Topic: Regulatory Frameworks

Using Public Regulatory Precedent for Model-Based Decisions

Timing Model Discussions Across Development Milestones

The FDA MIDD Paired Meeting Program

Resolving Divergent Agency Advice Across Regions

Revising an Agreed Model Strategy After New Evidence

Regulatory Authority of Laws, Regulations, Guidance, and Policies

Matching Model Questions to Regulatory Interaction Pathways

Interpreting Agency Meeting Records and Feedback

ICH Guideline Adoption and Regional Implementation

FDA Drug Development Tool Qualification for Modeling Methods